JP2023535620A5 - - Google Patents
Info
- Publication number
- JP2023535620A5 JP2023535620A5 JP2023505948A JP2023505948A JP2023535620A5 JP 2023535620 A5 JP2023535620 A5 JP 2023535620A5 JP 2023505948 A JP2023505948 A JP 2023505948A JP 2023505948 A JP2023505948 A JP 2023505948A JP 2023535620 A5 JP2023535620 A5 JP 2023535620A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- sequence
- seq
- acid sequence
- capsid protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2011871.7A GB202011871D0 (en) | 2020-07-30 | 2020-07-30 | Composition and method |
| GB2011871.7 | 2020-07-30 | ||
| PCT/GB2021/051985 WO2022023773A1 (en) | 2020-07-30 | 2021-07-30 | Composition and method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535620A JP2023535620A (ja) | 2023-08-18 |
| JP2023535620A5 true JP2023535620A5 (https=) | 2024-08-07 |
| JP7841821B2 JP7841821B2 (ja) | 2026-04-07 |
Family
ID=72425275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505948A Active JP7841821B2 (ja) | 2020-07-30 | 2021-07-30 | 組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230295237A1 (https=) |
| EP (1) | EP4188940A1 (https=) |
| JP (1) | JP7841821B2 (https=) |
| KR (1) | KR20230041820A (https=) |
| CN (1) | CN116406427A (https=) |
| AU (1) | AU2021319154A1 (https=) |
| BR (1) | BR112023001611A2 (https=) |
| CA (1) | CA3190289A1 (https=) |
| GB (1) | GB202011871D0 (https=) |
| WO (1) | WO2022023773A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3215311A1 (en) | 2021-04-01 | 2022-10-06 | The Regents Of The University Of California | Genetic modification of mammalian cells to confer resistance to csf1r antagonists |
| CA3254570A1 (en) * | 2022-03-24 | 2023-09-28 | Capsida, Inc. | ADENE-ASSOCIATED VIRUS COMPOSITIONS WITH INCREASED CARDIAC ENRICHEMENT |
| US20250312487A1 (en) * | 2022-05-13 | 2025-10-09 | Children's Medical Research Institute | Adeno-associated virus capsids |
| US20260108560A1 (en) * | 2022-07-13 | 2026-04-23 | The Regents Of The University Of California | Transplanting stem cell-derived microglia to treat leukodystrophies |
| EP4689140A2 (en) * | 2023-04-07 | 2026-02-11 | 4D Molecular Therapeutics Inc. | Aav variants for treatment of complement disorders |
| CN118480100B (zh) * | 2023-09-20 | 2025-04-04 | 广州派真生物技术有限公司 | 腺相关病毒突变体及其应用 |
| CN117660370B (zh) * | 2023-11-08 | 2025-03-21 | 中国人民解放军空军军医大学 | 一种重组腺相关病毒、抗炎药物及其在脓毒性脑病治疗中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2739288T3 (es) * | 2013-09-13 | 2020-01-30 | California Inst Of Techn | Recuperación selectiva |
| KR102423442B1 (ko) * | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
| EP3808849A1 (en) * | 2017-08-03 | 2021-04-21 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| WO2020028751A2 (en) * | 2018-08-03 | 2020-02-06 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
-
2020
- 2020-07-30 GB GBGB2011871.7A patent/GB202011871D0/en not_active Ceased
-
2021
- 2021-07-30 CN CN202180066253.7A patent/CN116406427A/zh active Pending
- 2021-07-30 KR KR1020237007325A patent/KR20230041820A/ko active Pending
- 2021-07-30 US US18/007,378 patent/US20230295237A1/en active Pending
- 2021-07-30 WO PCT/GB2021/051985 patent/WO2022023773A1/en not_active Ceased
- 2021-07-30 JP JP2023505948A patent/JP7841821B2/ja active Active
- 2021-07-30 EP EP21756024.2A patent/EP4188940A1/en active Pending
- 2021-07-30 BR BR112023001611A patent/BR112023001611A2/pt unknown
- 2021-07-30 CA CA3190289A patent/CA3190289A1/en active Pending
- 2021-07-30 AU AU2021319154A patent/AU2021319154A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023535620A5 (https=) | ||
| JP7374119B2 (ja) | 減少した肝臓向性を有するＡＡＶ９とＡＡＶｒｈ７４とのハイブリッド組換えアデノ随伴ウイルス血清型 | |
| JP2022508182A5 (https=) | ||
| JP6363958B2 (ja) | Ａａｖ変異体 | |
| JP2024009857A5 (https=) | ||
| JP2023504314A5 (https=) | ||
| JP2023544683A5 (https=) | ||
| JP2020048571A5 (https=) | ||
| JP2019116492A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| JP2022529631A5 (https=) | ||
| JP2018522529A5 (https=) | ||
| JP2022547197A5 (https=) | ||
| JP2022535749A5 (https=) | ||
| JP2022523679A5 (https=) | ||
| JP2020500541A5 (https=) | ||
| US20230049066A1 (en) | Novel aav3b variants that target human hepatocytes in the liver of humanized mice | |
| JP2022523719A (ja) | Ａａｖキャプシドの転写依存性定方向進化を使用するための方法 | |
| CN101511373A (zh) | 用于基因治疗的修饰的因子viii和因子ix基因和载体 | |
| JP2017529395A5 (https=) | ||
| JP2022541070A5 (https=) | ||
| JP2022551744A5 (https=) | ||
| JP2023537358A5 (https=) | ||
| EP3952920A1 (en) | Hybrid promoters for muscle expression | |
| JP2023524024A5 (https=) |